Nanobiotix S.A. (NBTX)
NASDAQ: NBTX
· Real-Time Price · USD
10.04
0.69 (7.38%)
At close: Sep 11, 2025, 3:59 PM
10.11
0.70%
After-hours: Sep 11, 2025, 06:44 PM EDT
7.38% (1D)
| Bid | 8.66 |
| Market Cap | 474.92M |
| Revenue (ttm) | -11.61M |
| Net Income (ttm) | -68.13M |
| EPS (ttm) | -1.69 |
| PE Ratio (ttm) | -5.94 |
| Forward PE | 29 |
| Analyst | Buy |
| Ask | 10.73 |
| Volume | 8,363 |
| Avg. Volume (20D) | 10,270 |
| Open | 9.87 |
| Previous Close | 9.35 |
| Day's Range | 9.59 - 10.19 |
| 52-Week Range | 2.76 - 10.59 |
| Beta | 1.58 |
About NBTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NBTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NBTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
+18.51%
Nanbotix shares are trading higher after the compa...
Unlock content with
Pro Subscription
7 months ago
+7.26%
Nanobiotix shares are trading higher after the company announced it began its Phase 2 trial for an innovative cancer treatment in stage 3 lung cancer.
